Skip to main content
All lobbying filings

NYU LANGONE HOSPITALS (FORMERLY NYU HOSPITALS CENTER)

Lobbying for NYU LANGONE HOSPITALS (FORMERLY NYU HOSPITALS CENTER)

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 16, 2026
Expenses
$50,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Government bodies contacted 3
  • Centers For Medicare and Medicaid Services (CMS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 3
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • HR 4313
    Hospital Inpatient Services Modernization Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 3
Medicare/Medicaid

- Provided feedback on draft kidney transplant legislation to improve patient access and care delivery - Advocated in support of H.R. 4299, the Protecting Patient Access to Cancer and Complex Therapies Act, to preserve timely access to complex and life-saving treatments for patients - Advocated in support of H.R. 4313, the Hospital Inpatient Services Modernization Act, to modernize inpatient care policies and improve hospital operations and patient access - Request for Delay in the Essential Plan Cuts to New York - Advocating against hits from the H.R.1 - One Big Beautiful Bill Act (Cap on Provider Taxes)(Limits on SDPs)(Medicaid Work/Eligibility Requirements)(Essential Plan Restrictions)(Affordable Care Act Premium Tax Credits) - Engagement with CMS on site-neutral/Medicare Advantage - Support for continuation of funding for Extenders (telehealth, H@H, Community Health Center Funding)

Budget/Appropriations

- Urged members of Congress to provide robust NIH funding in the FY 2026 Labor-HHS appropriations bill to support biomedical research and innovation - Engaged on Medicaid DSH cuts, health care extenders, Medicare Advantage and physician payment reforms, insurer practices, nutrition education, and site-neutral and value-based care policies to protect patient access and hospital sustainability

Health Issues

- Engaged on Medicaid DSH cuts, health care extenders, Medicare Advantage reforms, insurer practices, nutrition education, and site-neutral and value-based care policies to protect patient access and hospital sustainability - Provided feedback on draft kidney transplant legislation focused on improving patient access, care coordination, and transplant outcomes - Advocated on H.R. 1, 340B program protections, and site-neutral payment policies impacting hospital reimbursement and access to care - Advocated for robust federal funding for the National Institutes of Health (NIH) to support biomedical research, innovation, and clinical discovery - Engaged on Medicare Advantage and physician payment reforms, supported the Protecting Patient Access to Cancer and Complex Therapies Act - Advocated in support of H.R. 4313, the Hospital Inpatient Services Modernization Act, to modernize inpatient care policies and improve hospital operations and patient access - Discussed challenges posed by OBBBA to New York hospitals and identified opportunities for CMS to improve access, efficiency, and care delivery

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem